T. gondii, Schizophrenia, and other Psychiatric Disorders
Powerful evidence supports an association between the parasite Toxoplasma gondii and schizophrenia.
Risks of Marijuana
The combination of a large selection of products, poor labeling, and a lack of regulatory oversight in the states that have approved marijuana for recreational use has created a potentially dangerous situation for consumers, who receive little guidance regarding dosing.
Antipsychotics in Dementia: Quantifying the Mortality Risk
Antipsychotics are associated with an increase in mortality risk for patients with dementia. Alternative interventions should be considered first to treat agitation, aggression, and psychosis in this population
Schizophrenia Patients with Genetic Mutation Have Equal Response but More Serious Side Effects; Passage of Medical Marijuana Laws Does Not Increase Adolescent Use
Compromised Health in Schizophrenia: Venous Thromboembolism and Fractures
Patients with schizophrenia have an elevated risk of venous thromboembolism and fractures.
the source for
up-to-date information on psychotropic medications and other biological treatments for mental disorders
Register now, or if you are completing your residency and received a promotional mailing, enter your code.
Subscribing to BTP is easy! You can receive the print version with online access, or online only.
Dr. Gelenberg invites you to join him in Tucson, AZ the week of February 16, 2015 for the 2015 Update on Psychiatry conference. This 4-day live multi-accredited conference will be held at the JW Marriott Starr Pass. This year's program features outstanding speakers from our University and academic institutions around the country including Dr. Alan Gelenberg. Current clinical practices and research focusing on a variety of psychopharmacology topics will be addressed.
For more information and to register go to www.psychopharm.arizona.edu.
Question please contact Leticia Lovallo at firstname.lastname@example.org or 520.626.1392
- J. Rutherford, M.D.